89bio, Inc. (ETNB) is a clinical-stage biopharmaceutical company headquartered in San Francisco, California, specializing in the development of innovative therapies for liver and cardiometabolic diseases. The company focuses on addressing critical unmet medical needs through a promising pipeline of therapies that aim to enhance patient outcomes and overall quality of life. With a strong commitment to research and development, 89bio is strategically positioned to significantly contribute to advancements in the biopharmaceutical industry while creating sustainable shareholder value.
Click "Analyze" to generate stock analysis
ETNB Price Trend and Signals
ETNB Option Volumes & Open Interests (aggregated)
ETNB Put Call Ratios and IV (aggregated)
ETNB Financials
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.